Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    20926833 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Safety and Efficacy of AIN457 in Noninfectious Uveitis
Condition: Active Uveitis That is Not From an Infection.
Interventions: Drug: AIN457 subcutaneous dose;   Drug: AIN457 low dose (i.v);   Drug: AIN457 high dose (i.v)
2 Completed A Study Comparing AIN457 to Placebo in Subjects With a Diagnosis of Moderate to Severe Stable Plaque Psoriasis
Condition: Plaque Psoriasis
Interventions: Biological: AIN457;   Biological: Placebo
3 Completed Double Blind, Placebo-controlled, Study of the Safety, Tolerability and Pharmacokinetics of AIN457 in Rheumatoid Arthritis Patients
Condition: Rheumatoid Arthritis
Intervention: Biological: AIN457

Indicates status has not been verified in more than two years